Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/19/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Carlos Cordon-Cardo

Wrong Dr. Carlos Cordon-Cardo?

Professor and Chairman , Departme...

Mount Sinai School of Medicine
5 East 98th St Box 1188
New York , New York 10029
United States

Company Description: Located in Manhattan, Mount Sinai School of Medicine is internationally recognized for ground-breaking clinical and basic-science research, and innovative...   more

Employment History

Board Memberships and Affiliations


  • MD
  • PhD
  • Ph.D. , Cell Biology and Genetics
    Cornell University Medical College
  • M.D.
    Autonomous University of Barcelona , Spain
142 Total References
Web References
Board of Directors | Queen Sofía Spanish Institute - New York, 5 Mar 2015 [cached]
Carlos Cordón-Cardó, M.D., Ph. D.
Carlos Cordon-Cardo, MD, ..., 17 Feb 2015 [cached]
Carlos Cordon-Cardo, MD, PhD, a distinguished physician-scientist and recognized internationally for his groundbreaking research in experimental pathology and molecular oncology, holds the appointment of Chair for the Department of Pathology at The Mount Sinai Medical Center.
Dr. Cordon-Cardo is a leader in the mechanisms of tumor suppression. His research has focused on the analyses of multidrug resistance and alteration of tumor suppression genes in human cancer. He developed and implemented an oncologic molecular pathology discipline and helped create the "systems pathology" platform. This approach uses systems biology to form mathematical models of the interaction and behavior of cancer cells with the goal of determining tumor pathogenesis and clinical outcome.
Dr. Cordon-Cardo's contributions to cancer research have had important implications for tumor suppression, particularly in bladder and prostate cancers, and soft tissue sarcomas. Currently, his research is aimed at understanding the cooperative effects of mutations of cell-cycle regulation, and genes that prevent cell death cancer. Additionally, he is developing and characterizing animal models for loss of function of specific pathways by targeted gene disruption using bladder cancer and sarcomas. Recent studies from his laboratory have linked adult stem cells and cancer, revealing that certain tumors originate from distinct differentiation stages in stem-cell fate and development.
A frequently cited author, Dr. Cordon-Cardo has received National Cancer Institute funding for his research. He has developed numerous patents, is a dedicated mentor, and he holds prominent posts in several national and international professional organizations.
Dr. Cordon-Cardo has outlined a broad vision that redefines the discipline of Pathology, placing it at the core of patient management and individualized medicine. He is aggressively recruiting senior and junior faculty, identifying and developing subspecialty areas, such as molecular and systems pathology programs, and expanding biorepositories and databases to further enhance translational research, converting his vision into a reality.
Prior to joining Mount Sinai, Dr. Cordon-Cardo served as Vice-Chair of Pathology, Professor of Pathology, and Urology, and Associate Director for Infrastructure at the Herbert Irving Comprehensive Cancer Center at Columbia University College of Physicians and Surgeons. He also created the Division of Molecular Pathology at Memorial Sloan-Kettering Cancer Center and served as its first director.
Dr. Cordon-Cardo obtained his MD from the Autonomous University of Barcelona, Spain, in 1980, and his PhD in Cell Biology and Genetics from Cornell University Medical College in 1985.
In The News: Dr. Carlos Cordon-Cardo discusses new techniques in the fight against prostate cancer in The Daily News feature The Daily Check Up.
Below are financial relationships with industry reported by Dr. Cordon-Cardo during 2013 and/or 2014.
Exosome Diagnostics News - 05.24.11, 24 May 2011 [cached]
NEW YORK (NY, USA) May 24, 2011 - Exosome Diagnostics, a leading developer of biofluid based molecular diagnostic tests for use in personalised medicine, today announced the appointments of Bob Carter MD, PhD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board (SAB).
Dr. Cordon-Cardo is Vice Chairman of Pathology and Professor of Pathology and Urology at Columbia University in addition to being Associate Director of Infrastructure at the Herbert Irving Comprehensive Cancer Center. Dr. Cordon-Cardo obtained his M.D. from the Autonomous University of Barcelona, Spain, in 1980, and his Ph.D. in Cell Biology and Genetics from Cornell University Medical College in 1985. He has pioneered the development and implementation of an oncologic molecular pathology discipline, and more recently participated in the creation of the "systems pathology" platform. He is internationally recognized for his studies on experimental pathology and molecular oncology, including analyses of multidrug resistance and alterations of tumor suppressor genes in human cancer, mainly those deregulating cell cycle.
"This collaboration with ..., 24 Mar 2015 [cached]
"This collaboration with Philips has the potential to help drive a new paradigm in healthcare that includes the optimization of treatment efficacy and superior clinical outcomes," said Dr. Carlos Cordon-Cardo M.D., Ph.D., Chairman of the Department of Pathology at the Mount Sinai Health System.
Science Advisory Board - Exosome Diagnostics, Inc., 19 Dec 2011 [cached]
Carlos Cordon-Cardo, MD, PhD
Dr. Carlos Cordon-Cardo is Chair and Professor of Pathology at The Mount Sinai Medical Center, where he also serves as Professor of Oncological Sciences and of Genetics and Genomic Sciences. Prior to these positions, he was Professor of Pathology and Urology, and Associate Director for Infrastructure at the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center. To understand what causes variation in cancers as a means to provide better diagnoses, prognoses, and treatment for patients has been Dr. Cordon-Cardo's professional quest for the past 30 years as a research pathologist and cancer biologist. Dr. Cordon-Cardo has received a number of awards, including Membership on the "Roll of Honour" of the International Union Against Cancer (since 1996). Based on his scientific contributions, Dr. Cordon-Cardo has received numerous patents, and he has mentored over 70 investigators.
Other People with the name "Cordon-Cardo":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.